{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:18:28Z","timestamp":1791519508789,"version":"4.3.4"},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>The main intention of this retrospective study was to investigate whether chronic illicit drug abuse, especially the intravenous use of opioids (heroin), could potentially trigger the development of myocardial fibrosis in drug addicts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A retrospective case\u2013control study was performed using myocardial tissue samples from both drug\u2010related deaths (<jats:styled-content style=\"fixed-case\">DRD<\/jats:styled-content>) with verifiable opioid abuse and non\u2010drug\u2010related deaths in the same age group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>epartment of <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>orensic <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>edicine, <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>edical <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>niversity of <jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>ienna, <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ustria (1993\u201394).<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Myocardial specimens were retrieved from 76 deceased intravenous opioid users and compared to those of 23 deceased non\u2010drug users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Drug quantification was carried out using the enzyme\u2010multiplied immunoassay technique (<jats:styled-content style=\"fixed-case\">EMIT<\/jats:styled-content>), followed by [gas chromatography\u2013mass spectrometry (<jats:styled-content style=\"fixed-case\">GC<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>), <jats:styled-content style=\"fixed-case\">MAT<\/jats:styled-content> 112<jats:sup>\u00ae<\/jats:sup>], and analysed using the <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>ntegrator 3390<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> by <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ewlett <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ackard<jats:sup>\u00ae<\/jats:sup> and <jats:styled-content style=\"fixed-case\">LABCOM<\/jats:styled-content>.1 computer (<jats:styled-content style=\"fixed-case\">MSS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>.<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>.). The amount of fibrous connective tissue (<jats:styled-content style=\"fixed-case\">FCT<\/jats:styled-content>) in the myocardium was determined by using the morphometric software <jats:styled-content style=\"fixed-case\">LUCIA N<\/jats:styled-content>et version 1.16.2<jats:sup>\u00a9<\/jats:sup>, <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>aboratory <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>maging, with <jats:styled-content style=\"fixed-case\">NIS E<\/jats:styled-content>lements 3.0<jats:sup>\u00ae<\/jats:sup>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Drug analysis revealed that 67.11% were polydrug users and the same proportion was classified as heroin addicts (6\u2010monoacetylmorphine, 6\u2010<jats:styled-content style=\"fixed-case\">MAM<\/jats:styled-content>)\u201432.89% were users of pure heroin. In 76.32% of <jats:styled-content style=\"fixed-case\">DRD<\/jats:styled-content> cases, codeine was detected. Only 2.63% consumed cocaine. The mean morphine concentrations were 389.03\u2009ng\/g in the cerebellum and 275.52\u2009ng\/g in the medulla oblongata, respectively. Morphometric analysis exhibited a strong correlation between <jats:styled-content style=\"fixed-case\">DRD<\/jats:styled-content> and myocardial fibrosis. The mean proportion of <jats:styled-content style=\"fixed-case\">FCT<\/jats:styled-content> content in the drug group was 7.6\u2009\u00b1\u20092.9% (females: 6.30\u2009\u00b1\u20092.19%; males: 7.91\u2009\u00b1\u20093.01%) in contrast to 5.2\u2009\u00b1\u20091.7% (females: 4.45\u2009\u00b1\u20091.23%; males: 5.50\u2009\u00b1\u20091.78%) in the control group, indicating a significant difference (<jats:italic>P<\/jats:italic>\u2009=\u20090.0012), and a significant difference in the amount of <jats:styled-content style=\"fixed-case\">FCT<\/jats:styled-content> between females and males (<jats:italic>P<\/jats:italic>\u2009=\u20090.0383). There was no significant interaction of age and <jats:styled-content style=\"fixed-case\">FCT<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u2009=\u20090.8472).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is a long\u2010term risk of cardiac dysfunction following chronic illicit drug abuse with opioids as a principal component. Regular cardiological examination of patients receiving substitution treatment with morphine is strongly recommended.<\/jats:p><\/jats:sec>","DOI":"10.1111\/add.12106","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T19:10:49Z","timestamp":1357672249000},"page":"1287-1295","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Micromorphological changes in cardiac tissue of drug\u2010related deaths with emphasis on chronic illicit opioid abuse"],"prefix":"10.1111","volume":"108","author":[{"given":"Monika H.","family":"Seltenhammer","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Marchart","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Paula","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kordina","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Klupp","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fitzl","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele U.","family":"Risser","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).World Drug Report.2011.New York:United Nations Publication Sales no. E.11.XI.10."},{"key":"e_1_2_5_3_1","unstructured":"UhlA. SpringerA. KobrnaU. GnambsT. PfarrhoferD.Austrian wide representative ascertainment of substance\u2010use; ascertainment 2008 Volume 1: Research report. Vienna: Federal Ministry for Health;2009."},{"key":"e_1_2_5_4_1","unstructured":"UhlA. SeidlerD.Prevalence Estimate of Problematic Opiate Consumption in Austria 2nd revised edn. Vienna: Ludwig Boltzmann Institute for Addiction Research (LBISucht) 2001. Available at:http:\/\/www.api.or.at\/lbi\/pdf\/prevest.pdf(Archived by WebCite\u00ae athttp:\/\/www.webcitation.org\/6FTtVR8Sson 29 March 2013) (accessed 15 August 2006)."},{"key":"e_1_2_5_5_1","unstructured":"Austrian Federal Institute for Public Health.Drug report 2005.Vienna Austria:Federal Institute for Public Health 2008."},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS14180J"},{"key":"e_1_2_5_7_1","unstructured":"Federal Ministry of Internal Affairs.Drug report 1994. Vienna Austria: Federal Ministry of the Interior 1995."},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00150-2"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2007.00507.x"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000141645"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070392"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01495.x"},{"key":"e_1_2_5_13_1","volume-title":"Karch's Pathology of Drug Abuse","author":"Karch S. B.","year":"2009"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03728.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2009.02.014"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90841-2"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(79)90288-3"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-78-1-25"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.08.020"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-5-15"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000046452.67724.B8"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(05)70154-5"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000118586.38323.5b"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000238387.85144.92"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00032-8"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00988.x"},{"key":"e_1_2_5_27_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Collection and Analysis of Information on Drug\u2010Related Deaths EMCDDA Scientific Report[online]. Lisbon Portugal: Union Monitoring Centre for Drugs and Drug Addiction 2001. Available at:http:\/\/www.emcdda.europa.eu\/?nnodeid=1419(Archived by WebCite\u00ae athttp:\/\/www.webcitation.org\/6FTt9bNSMon 29 March 2013) (accessed 5 July 2006)."},{"key":"e_1_2_5_28_1","first-page":"263","article-title":"Comparative morphine determination in parts of the brain using combined gas chromatography\/mass spectrometry. A possibility for assessing survival time","volume":"99","author":"Vycudilik W.","year":"1988","journal-title":"Z Rechtsmed"},{"key":"e_1_2_5_29_1","volume-title":"The Pharmacological Basis of Therapeutics","author":"Brunton L.","year":"1991"},{"key":"e_1_2_5_30_1","volume-title":"Base SAS\u00ae 9.2 Procedures Guide","author":"SAS Institute Inc","year":"2011"},{"key":"e_1_2_5_31_1","first-page":"198","article-title":"Infectious endocarditis and sudden unexpected death: incidence and morphology of lesions in intravenous addicts and non\u2010drug abusers","volume":"6","author":"Burke A. P.","year":"1997","journal-title":"J Heart Valve Dis"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2011.01717.x"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197352030-00005"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hdx.0000080713.09303.a6"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.paf.0000159990.54730.4b"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.61.781"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.4.433"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.55.6.575"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.14.1729"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01101.x"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2008.04930.x"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000124251.06056.8e"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.165043"},{"key":"e_1_2_5_44_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction.Polydrug Use: Patterns and Responses. Luxembourg Publications Office of the European Union 2009. Available at:http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_93217_EN_EMCDDA_SI09_polydrug%20use.pdf(Archived by WebCite\u00ae athttp:\/\/www.webcitation.org\/6FTtmBXolon 29 March 2013) (accessed 25 March 2013)."},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473710801030297"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903436044"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.12106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.12106","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.12106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T22:24:44Z","timestamp":1698704684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/add.12106"],"URL":"https:\/\/doi.org\/10.1111\/add.12106","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]},"assertion":[{"value":"2012-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}